Shenzhen Neptunus Bioengineering plans to raise CNY1bn ($150.69m) through the private placement of debt financing instruments.
The Chinese biochemical pharmaceuticals company plans to use the funds towards gold operations and repayment of debt.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Indian pharmaceutical company Denis Chem Lab plans to issue 21 million shares of its common stock priced at Rs84 ($1.31) a share to raise Rs179.32m ($2.8m).
Chinese healthcare solutions provider Humanwell Healthcare (Group) plans to dispose its bio-pharma unit for CNY350m ($53.01m).
